StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Interpace Biosciences's total debt was $1.34M at Mar 31, 2024. For fiscal 2023 it was $4.24M, down 63.9% from the year before. The highest annual figure on record is $27.15M in fiscal 2014.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$4.24M-63.9%
FY2022Dec 31, 2022$11.74M+816.0%
FY2021Dec 31, 2021$1.28M-73.7%
FY2020Dec 31, 2020$4.88M+15.7%
FY2019Dec 31, 2019$4.22M-46.6%
FY2016Dec 31, 2016$7.91M-5.8%
FY2015Dec 31, 2015$8.40M-69.1%
FY2014Dec 31, 2014$27.15M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$1.34M-88.5%
Q4 FY2023Dec 31, 2023$4.24M-63.9%
Q3 FY2023Sep 30, 2023$11.57M+1257.4%
Q2 FY2023Jun 30, 2023$11.31M+201.8%
Q1 FY2023Mar 31, 2023$11.67M+189.1%
Q4 FY2022Dec 31, 2022$11.74M+816.0%
Q3 FY2022Sep 30, 2022$852.00K-80.4%
Q2 FY2022Jun 30, 2022$3.75M-11.1%
Q1 FY2022Mar 31, 2022$4.04M-9.9%
Q4 FY2021Dec 31, 2021$1.28M-73.7%
Q3 FY2021Sep 30, 2021$4.36M-13.3%
Q2 FY2021Jun 30, 2021$4.22M-20.7%
Q1 FY2021Mar 31, 2021$4.48M+55.6%
Q4 FY2020Dec 31, 2020$4.88M+15.7%
Q3 FY2020Sep 30, 2020$5.02M+9.7%
Q2 FY2020Jun 30, 2020$5.32M+21.9%
Q1 FY2020Mar 31, 2020$2.88M-63.6%
Q4 FY2019Dec 31, 2019$4.22M-53.2%
Q3 FY2019Sep 30, 2019$4.58M–
Q1 FY2017Mar 31, 2017$4.36M–
Q4 FY2016Dec 31, 2016$7.91M–
Q3 FY2016Sep 30, 2016$9.02M–

More Interpace Biosciences figures

See a number that looks wrong?